Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Holmberg

Showing results (71-80 of 287) with videos related to

Pageof 29
Sort By:
Breast Cancer Research and Treatment|August 6, 2016
Effect of selective serotonin reuptake inhibitors use on endocrine therapy adherence and breast cancer mortality: a population-based studyAntonis Valachis, Hans Garmo, John Weinman, et al.
Drug and Alcohol Dependence|May 26, 2015
Anabolic steroids and cardiovascular risk: A national population-based cohort studyIngemar Thiblin, Hans Garmo, Mats Garle, et al.
European Urology|September 12, 2008
Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trialEva Johansson, Anna Bill-Axelson, Lars Holmberg, et al.
International Journal of Cancer|October 11, 2008
Social differences in breast cancer survival in relation to patient management within a National Health Care System (Sweden)Sonja Eaker, Märit Halmin, Rino Bellocco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2011
Distribution of coronary artery stenosis after radiation for breast cancerGreger Nilsson, Lars Holmberg, Hans Garmo, et al.
Acta Oncologica (Stockholm, Sweden)|October 21, 2014
Cyclin E1 is a strong prognostic marker for death from lymph node negative breast cancer. A population-based case-control studyClaudia Lundgren, Cecilia Ahlin, Lars Holmberg, et al.
Plos One|June 14, 2016
Associations of C-Reactive Protein, Granulocytes and Granulocyte-to-Lymphocyte Ratio with Mortality from Breast Cancer in Non-Institutionalized American WomenWahyu Wulaningsih, Lars Holmberg, Lucie Abeler-Doner, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 21, 2005
Regional differences in breast cancer survival despite common guidelinesSonja Eaker, Paul W Dickman, Vivan Hellström, et al.
Plos One|April 19, 2017
Ghrelin is a prognostic marker and a potential therapeutic target in breast cancerMalin Grönberg, Cecilia Ahlin, Ylva Naeser, et al.
European Urology|January 20, 2016
Work Disability After Robot-assisted or Open Radical Prostatectomy: A Nationwide, Population-based StudyAnna Plym, Flaminia Chiesa, Margaretha Voss, et al.
Pageof 29

Showing results (71-80 of 287) with videos related to

Sort By:
Pageof 29
Breast Cancer Research and Treatment|August 6, 2016
Effect of selective serotonin reuptake inhibitors use on endocrine therapy adherence and breast cancer mortality: a population-based studyAntonis Valachis, Hans Garmo, John Weinman, et al.
Drug and Alcohol Dependence|May 26, 2015
Anabolic steroids and cardiovascular risk: A national population-based cohort studyIngemar Thiblin, Hans Garmo, Mats Garle, et al.
European Urology|September 12, 2008
Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trialEva Johansson, Anna Bill-Axelson, Lars Holmberg, et al.
International Journal of Cancer|October 11, 2008
Social differences in breast cancer survival in relation to patient management within a National Health Care System (Sweden)Sonja Eaker, Märit Halmin, Rino Bellocco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 29, 2011
Distribution of coronary artery stenosis after radiation for breast cancerGreger Nilsson, Lars Holmberg, Hans Garmo, et al.
Acta Oncologica (Stockholm, Sweden)|October 21, 2014
Cyclin E1 is a strong prognostic marker for death from lymph node negative breast cancer. A population-based case-control studyClaudia Lundgren, Cecilia Ahlin, Lars Holmberg, et al.
Plos One|June 14, 2016
Associations of C-Reactive Protein, Granulocytes and Granulocyte-to-Lymphocyte Ratio with Mortality from Breast Cancer in Non-Institutionalized American WomenWahyu Wulaningsih, Lars Holmberg, Lucie Abeler-Doner, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 21, 2005
Regional differences in breast cancer survival despite common guidelinesSonja Eaker, Paul W Dickman, Vivan Hellström, et al.
Plos One|April 19, 2017
Ghrelin is a prognostic marker and a potential therapeutic target in breast cancerMalin Grönberg, Cecilia Ahlin, Ylva Naeser, et al.
European Urology|January 20, 2016
Work Disability After Robot-assisted or Open Radical Prostatectomy: A Nationwide, Population-based StudyAnna Plym, Flaminia Chiesa, Margaretha Voss, et al.
Pageof 29